TELA Bio, Inc. (TELA)
Data as of , from SEC Form 4 filings.
See up to 3 months of TELA. The 7-day demo opens the 1M and 3M ranges and puts TELA on your watchlist.
Start 7-day demoLatest TELA insider trades
Joseph H. Capper - DirectorOpen-market purchase$58K- Joseph H. Capper - DirectorOpen-market purchase$31K
- Joseph H. Capper - DirectorOpen-market purchase$26K
- Joseph H. Capper - DirectorOpen-market purchase$53K
- Heather C. Getz - OfficerOpen-market purchase$8K
- Heather C. Getz - OfficerOpen-market purchase$10K
- EW HEALTHCARE PARTNERS FUND 2, L.P.Open-market purchase$4.00M
- Roberto Cuca - OfficerOpen-market purchase$145K
About TELA Bio, Inc. (TELA)
TELA Bio Inc a commercial-stage medical technology company focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.
- MALVERN, PA
- 218
- 2019
- XNAS
TELA Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 6 | 177,500 | $186K |
| Grant or award | 5 | 2,897,157 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
TELA insider transactions (Form 4)
7031 Form 4 filings on record, the earliest from Oct 24, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Joseph H. Capper - Director | Open-market purchase | Common Stock | 50,000 | $1.17 footnote F1 | $58K | |
| Joseph H. Capper - Director | Open-market purchase | Common Stock | 25,000 | $1.22 footnote F2 | $31K | |
| ||||||
| Joseph H. Capper - Director | Open-market purchase | Common Stock | 25,000 | $1.02 footnote F1 | $26K | |
| Joseph H. Capper - Director | Open-market purchase | Common Stock | 50,000 | $1.06 footnote F2 | $53K | |
| ||||||
| Heather C. Getz - Officer | Open-market purchase | Common Stock | 12,500 | $0.66 footnote F1 | $8K | |
| ||||||
| Heather C. Getz - Officer | Open-market purchase | Common Stock | 15,000 | $0.70 footnote F1 | $10K | |
| ||||||
| Heather C. Getz - Officer | Grant or award | Common Stock | 500,000 footnote F1 | $0.00 | - | |
| Heather C. Getz - Officer | Grant or award | Stock Option (Right to Buy) | 1,365,000 | $0.00 | - | |
| Heather C. Getz - Officer | Grant or award | Stock Option (Right to Buy) | 1,005,000 | $0.00 | - | |
| ||||||
| William J. Plovanic | Grant or award | Common Stock | 20,930 footnote F1 | $0.79 | $16K | |
| ||||||
| Joseph H. Capper | Grant or award | Common Stock | 6,227 footnote F1 | $0.79 | $5K | |
| ||||||
 Betty Jo Rocchio | Grant or award | Common Stock | 11,675 footnote F1 | $0.00 | - | |
| Betty Jo Rocchio | Grant or award | Stock Option (Right to Buy) | 17,335 | $0.00 | - | |
| ||||||
| Joseph H. Capper | Grant or award | Stock Option (Right to Buy) | 17,550 | $0.00 | - | |
| Joseph H. Capper | Grant or award | Stock Option (Right to Buy) | 17,335 | $0.00 | - | |
| Joseph H. Capper | Grant or award | Common Stock | 11,925 footnote F1 | $0.00 | - | |
| Joseph H. Capper | Grant or award | Common Stock | 11,675 footnote F2 | $0.00 | - | |
| ||||||
| William J. Plovanic | Grant or award | Common Stock | 11,675 footnote F1 | $0.00 | - | |
| William J. Plovanic | Grant or award | Stock Option (Right to Buy) | 17,335 | $0.00 | - | |
| ||||||
 Guido J. Neels | Grant or award | Stock Option (Right to Buy) | 17,335 | $0.00 | - | |
| Guido J. Neels | Grant or award | Common Stock | 11,925 footnote F1 | $0.00 | - | |
| Guido J. Neels | Grant or award | Common Stock | 11,675 footnote F2 | $0.00 | - | |
| Guido J. Neels | Grant or award | Stock Option (Right to Buy) | 17,550 | $0.00 | - | |
| ||||||
| Paul Thomas | Grant or award | Stock Option (Right to Buy) | 17,335 | $0.00 | - | |
| Paul Thomas | Grant or award | Common Stock | 11,925 footnote F1 | $0.00 | - | |
| Paul Thomas | Grant or award | Common Stock | 11,675 footnote F2 | $0.00 | - | |
| Paul Thomas | Grant or award | Stock Option (Right to Buy) | 17,550 | $0.00 | - | |
| ||||||
| Guy P. Nohra | Grant or award | Stock Option (Right to Buy) | 17,335 | $0.00 | - | |
| Guy P. Nohra | Grant or award | Common Stock | 11,925 footnote F1 | $0.00 | - | |
| Guy P. Nohra | Grant or award | Common Stock | 11,675 footnote F2 | $0.00 | - | |
| Guy P. Nohra | Grant or award | Stock Option (Right to Buy) | 17,550 | $0.00 | - | |
| ||||||
| Antony Koblish - Officer | Grant or award | Common Stock | 176,000 footnote F1 | $0.00 | - | |
| Antony Koblish - Officer | Tax withholding / forfeiture | Common Stock | 12,494 footnote F2 | $0.72 | $9K | |
| Antony Koblish - Officer | Tax withholding / forfeiture | Common Stock | 11,631 footnote F2 | $0.77 | $9K | |
| Antony Koblish - Officer | Tax withholding / forfeiture | Common Stock | 3,900 footnote F2 | $0.79 | $3K | |
| Antony Koblish - Officer | Grant or award | Stock Option (Right to Buy) | 261,000 | $0.00 | - | |
| ||||||
| Gregory A. Firestone - Officer | Grant or award | Common Stock | 37,000 footnote F1 | $0.00 | - | |
| Gregory A. Firestone - Officer | Tax withholding / forfeiture | Common Stock | 4,189 footnote F3 | $0.72 | $3K | |
| Gregory A. Firestone - Officer | Tax withholding / forfeiture | Common Stock | 1,352 footnote F3 | $0.77 | $1K | |
| Gregory A. Firestone - Officer | Grant or award | Stock Option (Right to Buy) | 55,000 | $0.00 | - | |
| ||||||
| Paul Talmo - Officer | Grant or award | Common Stock | 57,000 footnote F1 | $0.00 | - | |
| Paul Talmo - Officer | Tax withholding / forfeiture | Common Stock | 3,385 footnote F2 | $0.72 | $2K | |
| Paul Talmo - Officer | Tax withholding / forfeiture | Common Stock | 4,061 footnote F2 | $0.77 | $3K | |
| Paul Talmo - Officer | Grant or award | Stock Option (Right to Buy) | 85,000 | $0.00 | - | |
| ||||||
| Roberto Cuca - Officer | Grant or award | Common Stock | 57,000 footnote F1 | $0.00 | - | |
| Roberto Cuca - Officer | Tax withholding / forfeiture | Common Stock | 4,780 footnote F3 | $0.72 | $3K | |
| Roberto Cuca - Officer | Tax withholding / forfeiture | Common Stock | 5,234 footnote F3 | $0.77 | $4K | |
| Roberto Cuca - Officer | Grant or award | Stock Option (Right to Buy) | 85,000 | $0.00 | - | |
| ||||||
| Jeffrey Blizard - Officer | Grant or award | Common Stock | 86,000 footnote F1 | $0.00 | - | |
| Jeffrey Blizard - Officer | Grant or award | Stock Option (Right to Buy) | 127,000 | $0.00 | - | |
| ||||||
| Megan Smeykal - Officer | Grant or award | Common Stock | 32,850 footnote F1 | $0.00 | - | |
| Megan Smeykal - Officer | Tax withholding / forfeiture | Common Stock | 795 footnote F2 | $0.80 | $632 | |
| Megan Smeykal - Officer | Tax withholding / forfeiture | Common Stock | 1,590 footnote F2 | $0.72 | $1K | |
| Megan Smeykal - Officer | Tax withholding / forfeiture | Common Stock | 423 footnote F2 | $0.77 | $324 | |
| ||||||
| EW HEALTHCARE PARTNERS FUND 2, L.P. | Open-market purchase | Common Stock, par value $0.001 per share | 3,604,000 footnote F1 | $1.11 | $4.00M | |
| ||||||
| William J. Plovanic | Grant or award | Common Stock | 11,925 footnote F1 | $0.00 | - | |
| William J. Plovanic | Grant or award | Stock Option (Right to Buy) | 17,550 | $0.00 | - | |
| ||||||
| Betty Jo Rocchio | Grant or award | Common Stock | 11,925 footnote F1 | $0.00 | - | |
| Betty Jo Rocchio | Grant or award | Stock Option (Right to Buy) | 17,550 | $0.00 | - | |
| ||||||
| Gregory A. Firestone - Officer | Tax withholding / forfeiture | Common Stock | 1,093 | $1.86 | $2K | |
| Douglas G. Evans - Director | Grant or award | Common Stock | 7,950 | $0.00 | - | |
| Douglas G. Evans - Director | Grant or award | Stock Option (Right to Buy) | 11,700 | $0.00 | - | |
| Lisa N. Colleran - Director | Grant or award | Common Stock | 7,950 | $0.00 | - | |
| Lisa N. Colleran - Director | Grant or award | Stock Option (Right to Buy) | 11,700 | $0.00 | - | |
| Federica F. O'Brien - Director | Grant or award | Common Stock | 7,950 | $0.00 | - | |
| Federica F. O'Brien - Director | Grant or award | Stock Option (Right to Buy) | 11,700 | $0.00 | - | |
| Antony Koblish - Officer | Tax withholding / forfeiture | Common Stock | 384 | $1.22 | $468 | |
| Roberto Cuca - Officer | Open-market purchase | Common Stock | 64,444 | $2.25 | $145K | |
| Paul Talmo - Officer | Open-market purchase | Common Stock | 22,222 | $2.25 | $50K | |
| Antony Koblish - Officer | Open-market purchase | Common Stock | 88,888 | $2.25 | $200K | |
Item 5.07
Item 8.01
Item 8.01, 9.01
Item 1.01
Item 3.01
TELA insider trading FAQ
What is the latest insider trade for TELA?
TELA Bio, Inc. (TELA) had 7 insider filings in the last 90 days, with the most recent on 2026-09-18. The full record for TELA runs to 31 Form 4 filings, the earliest from 2024-10-24. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying TELA stock?
6 insider purchases of TELA were filed in the last 90 days, totaling $186K.
How many insiders are selling TELA stock?
No insider sales of TELA were filed in the last 90 days.
Where can I see TELA SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects TELA Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Joseph H. Capper view on EDGAR
- - Joseph H. Capper view on EDGAR
- - Heather C. Getz view on EDGAR
- - Heather C. Getz view on EDGAR
- - Heather C. Getz view on EDGAR
- - William J. Plovanic view on EDGAR
- - Joseph H. Capper view on EDGAR
- - Betty Jo Rocchio view on EDGAR
- - Joseph H. Capper view on EDGAR
- - William J. Plovanic view on EDGAR
Related companies with recent insider activity
Learn more
- How to read insider buying signals
- What an open-market purchase by an insider can and cannot tell you.
- Insider activity in Health Care
- Where TELA's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow TELA with a 7-day demo
- TELA on your watchlist
- Every TELA Form 4 filing on record
- Up to 3 months of TELA price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.